155 related articles for article (PubMed ID: 37840069)
1. Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.
Macedo-Silva C; Miranda-Gonçalves V; Tavares NT; Barros-Silva D; Lencart J; Lobo J; Oliveira Â; Correia MP; Altucci L; Jerónimo C
Signal Transduct Target Ther; 2023 Oct; 8(1):395. PubMed ID: 37840069
[TBL] [Abstract][Full Text] [Related]
2. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
3. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic mechanisms underlying prostate cancer radioresistance.
Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
[TBL] [Abstract][Full Text] [Related]
5. Profiles of Radioresistance Mechanisms in Prostate Cancer.
Chaiswing L; Weiss HL; Jayswal RD; Clair DKS; Kyprianou N
Crit Rev Oncog; 2018; 23(1-2):39-67. PubMed ID: 29953367
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
7. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
8. Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG.
Nikolaev A; Fiveash JB; Yang ES
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940975
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and p53 regulate critical prostate cancer pathways.
De Luca P; Moiola CP; Zalazar F; Gardner K; Vazquez ES; De Siervi A
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):233-8. PubMed ID: 23670255
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of Hepatoma Up-Regulated Protein Inhibits γ-Irradiation-Induced Apoptosis of Prostate Cancer Cells.
Hassan M; El Khattouti A; Ejaeidi A; Ma T; Day WA; Espinoza I; Vijayakumar S; Gomez CR
J Cell Biochem; 2016 Jun; 117(6):1308-18. PubMed ID: 26505164
[TBL] [Abstract][Full Text] [Related]
12. Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells.
Wu Y; Liu P; Chen W; Bai S; Chen S; Chen J; Xu X; Xia J; Wu Y; Lai J; Sun C; Lao Z; Wan X; Wu Z
Int J Hyperthermia; 2024; 41(1):2335201. PubMed ID: 38583875
[TBL] [Abstract][Full Text] [Related]
13. Antagonizing CD105 enhances radiation sensitivity in prostate cancer.
Madhav A; Andres A; Duong F; Mishra R; Haldar S; Liu Z; Angara B; Gottlieb R; Zumsteg ZS; Bhowmick NA
Oncogene; 2018 Aug; 37(32):4385-4397. PubMed ID: 29717261
[TBL] [Abstract][Full Text] [Related]
14. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
15. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic bases of prostate tumor cell radioresistance.
Kutilin D
Klin Onkol; 2021; 34(3):220-234. PubMed ID: 34362257
[TBL] [Abstract][Full Text] [Related]
18. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.
Castellini L; Moon EJ; Razorenova OV; Krieg AJ; von Eyben R; Giaccia AJ
Nucleic Acids Res; 2017 Apr; 45(7):3674-3692. PubMed ID: 28073943
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
20. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
